scholarly journals Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy

Small ◽  
2017 ◽  
Vol 14 (4) ◽  
pp. 1702103 ◽  
Author(s):  
Nianxi Zhao ◽  
Zihua Zeng ◽  
Youli Zu
2020 ◽  
Vol 92 (22) ◽  
pp. 15179-15186
Author(s):  
Yuhong Lin ◽  
Yuqing Huang ◽  
Yuling Yang ◽  
Lili Jiang ◽  
Chao Xing ◽  
...  

2017 ◽  
Vol 38 (6) ◽  
pp. 848-858 ◽  
Author(s):  
Junseok Lee ◽  
Jinhwan Kim ◽  
Yeong Mi Lee ◽  
Dongsik Park ◽  
Sooseok Im ◽  
...  

2011 ◽  
Vol 121 (4) ◽  
pp. 2239-2249 ◽  
Author(s):  
Kishor Sarkar ◽  
Rishi Srivastava ◽  
Urmi Chatterji ◽  
P. P. Kundu
Keyword(s):  

2016 ◽  
Vol 8 (37) ◽  
pp. 24319-24324 ◽  
Author(s):  
Hongzhong Chen ◽  
Huijun Phoebe Tham ◽  
Chung Yen Ang ◽  
Qiuyu Qu ◽  
Lingzhi Zhao ◽  
...  

Polymers ◽  
2018 ◽  
Vol 10 (10) ◽  
pp. 1133 ◽  
Author(s):  
Jin Kim ◽  
Myeong Moon ◽  
Dong Kim ◽  
Suk Heo ◽  
Yong Jeong

Hyaluronic acid (HA) is a nonsulfated glycosaminoglycan and a major component of the extracellular matrix. HA is overexpressed by numerous tumor cells, especially tumor-initiating cells. HA-based nanomaterials play in importance role in drug delivery systems. HA is used in various types of nanomaterials including micelle, polymersome, hydrogel, and inorganic nanoparticle formulations. Many experiments show that HA-based nanomaterials can serve as a platform for targeted chemotherapy, gene therapy, immunotherapy, and combination therapy with good potential for future biomedical applications in cancer treatment.


2019 ◽  
Vol 7 (5) ◽  
pp. 2174-2190 ◽  
Author(s):  
Jungju Oh ◽  
Jaewon Lee ◽  
Chunxian Piao ◽  
Ji Hoon Jeong ◽  
Minhyung Lee

A self-assembled nanoparticle composed of hypoxia-specific anti-RAGE peptide (HSAP), heme oxygenase-1 plasmid (pHO1), and deoxycholate-conjugated polyethylenimine-2k (DP2k) was developed for ischemic stroke therapy.


2020 ◽  
Author(s):  
Yeong Chae Ryu ◽  
Kyungah Kim ◽  
Byoung Choul Kim ◽  
Hui-Min David Wang ◽  
Byeong Hee Hwang

Abstract Background: Gene therapy using siRNA can be a new potent strategy to treat many incurable diseases at the genetic level, including cancer and viral infections. Treatments using siRNA essentially requires an efficient and safe method of delivering siRNA into cells while maintaining its stability. Thus, we designed novel synergistic fusion peptides, i.e., SPACE and oligoarginine.Results: Among the novel fusion peptides and siRNAs, nanocomplexes have outstanding cellular uptake and gene silencing effect in vitro and high stability and retention effect of siRNAs in vivo. Oligo arginine could attract siRNAs electrostatically to form stable and self-assembled nanocomplexes, and the SPACE peptide could interact with the cellular membrane via hydrogen bonding. Therefore, nanocomplexes using fusion peptides showed improved and evident cellular uptake and gene silencing of Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) via the lipid raft-mediated endocytosis pathway, especially to the HDFn cells of the skin, and all of the fusion peptides were biocompatible. Also, intratumorally injected nanocomplexes had increased stability and retention of siRNAs at the site of the tumor. Conclusions: The new nanocomplex strategy could become a safe and efficient platform for the delivery of siRNAs into cells and tissues to treat various target diseases through gene therapy.


2020 ◽  
Vol 28 (1) ◽  
pp. 293-303 ◽  
Author(s):  
Da Sun ◽  
Rebecca M. Schur ◽  
Avery E. Sears ◽  
Song-Qi Gao ◽  
Amita Vaidya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document